Introduction
============

Somatic symptom disorder (SSD) is conceptualized as a psychiatric disorder, which shows an excess degree of suffering beyond that resulting from the presence of somatic symptoms alone, as defined in the *Diagnostic and Statistical Manual of Mental Disorders* (DSM), Fifth Edition.[@b1-jpr-10-1411] The diagnostic criteria consist of the following: one or more somatic symptoms that disrupt patients' daily life (criterion A); excessive thoughts, feelings, or behaviors related to their symptoms (criterion B); and a symptomatic state that typically persists for more than six months (criterion C).[@b2-jpr-10-1411] SSD encompasses somatization disorder, undifferentiated somatoform disorder (SFD), pain disorder, and hypochondriasis (with somatic symptoms) of SFD as defined in DSM-IV,[@b1-jpr-10-1411] although excessive inclusion of patients is a concern,[@b3-jpr-10-1411] and can be diagnosed with or without the presence of medical disease (MD).[@b2-jpr-10-1411] In this study, because these various names may be confusing, we use the term SSD to encompass all the terms that are included in the concept of SSD.

SSD is common because somatization accounts for 10% of primary care patients, which is the same prevalence as depression and anxiety.[@b4-jpr-10-1411] However, because SSD is one of the most difficult diseases to diagnose,[@b5-jpr-10-1411] doctors may order unnecessary diagnostic procedures to avoid overlooking MD.[@b6-jpr-10-1411] Such excessive interventions can foster somatic fixations of patients,[@b7-jpr-10-1411] leading to functional impairment, higher disability days, and increased health care costs.[@b4-jpr-10-1411] In addition, the early detection of mental illness is critical even for patients with somatic disease because mental treatments are recommended as soon as possible so as to prevent chronic state.[@b8-jpr-10-1411] Thus, there is a need to develop a comprehensive biopsychosocial approach that may be applied at an early stage.[@b6-jpr-10-1411]

However, no gold standard diagnostic method has been established for SSD.[@b9-jpr-10-1411] Even the diagnostic criteria of the DSM-5 necessitate clinical experience when making assessments.[@b10-jpr-10-1411] Moreover, previous studies have used various terms for medically unexplained physical symptoms (MUPS), such as somatization, SFD, and functional somatic symptom,[@b11-jpr-10-1411] and these various definitions and methods might have led to inconsistent conclusions.[@b12-jpr-10-1411] Thus, SSD and its clinical features in particular have scarcely been studied.[@b13-jpr-10-1411]

SSD patients may complain of various symptoms including pain, fatigue, and issues pertaining to gastrointestinal, cardiopulmonary, urogenital, neurological, skin and glands, or autonomic systems.[@b14-jpr-10-1411] Here, we studied patients with pain, which is common but of which it is challenging for doctors to determine the causes. Our objective was to develop a clinical score for discriminating patients with SSD from those with MD because physicians frequently are unable to identify the principal cause of pain between the two types of disorders, and worry about overlooking MD. We do not encourage mind--body dualism, and one reason for "excluding MD", as abolished in the DSM-5, is related to limited reliability for determining patients' symptoms as MUPS.[@b2-jpr-10-1411] Accordingly, clinical features of SSD were compared to those of MD to develop our clinical score.

Methods
=======

Study population
----------------

This was a retrospective cross-sectional study conducted at a university hospital in Japan. We investigated the medical records of consecutive patients who visited the Department of General Medicine at Chiba University Hospital with pain from April 2003 to March 2015. We list the classification of patients in [Figure 1](#f1-jpr-10-1411){ref-type="fig"}. Because the purpose of this study was to investigate differences in clinical features between SSD and MD, we excluded patients complaining of acute pain, which doctors rarely consider as SSD. We defined acute pain as that with a duration of less than one month since onset because acute pain generally improves within several weeks.[@b15-jpr-10-1411] Patients were also excluded if their final diagnoses were undetermined or if we could not understand them in sufficient detail due to language problems, dementia, an uncooperative attitude, mental retardation, or deafness. Because the clinical features of mental disorders other than SSD, such as depression or anxiety, have been established and these disorders contribute independently to functional impairment,[@b4-jpr-10-1411] such disorders should be evaluated before considering whether a patient might be suffering from SSD in primary care settings. Therefore, patients with a chief diagnosis of a mental disorder other than SSD, including those comorbid with SSD, were also excluded.

Confirmation of diagnoses
-------------------------

Our department has a system whereby two or more physicians examine each patient, and spend sufficient time to evaluate biopsychosocial problems, because most patients visiting our department are referred with unknown diagnostics from primary or secondary medical institutions. If a diagnosis is inconsistent or unclear among the physicians, they consult another senior physician or specialist, or follow up until a final diagnosis is determined. Diagnoses of mental disorder were previously based on the DSM-IV and are currently based on the DSM-5, or by referral to psychiatrists in daily medical practice. When extracting the data for this study, two physicians independently checked the clinical records to determine the final diagnosis (thus, a total of four or more physicians confirmed each diagnosis), and the diagnoses of mental disorder, including SSD, were reconfirmed based on the DSM-5. If the final diagnosis was in doubt, further discussion took place with the physicians in charge of the patient. However, because there is no widely accepted method to diagnose SSD,[@b9-jpr-10-1411] reliability of the diagnosis is an important problem. We classified patients as having "definite SSD" for developing a diagnostic score based on confirmed diagnosis of SSD if two or more physicians and a psychiatrist in our hospital diagnosed SSD with no alteration of diagnosis after follow-up. Patients were classified as having "probable SSD" for validating the model if the diagnosis was by physicians without an evaluation by psychiatrists in our hospital, even if there existed a consistent diagnosis made by psychiatrists in other institutions. Although the concept of functional somatic syndrome (FSS) overlaps with SSD, patients with FSS who also meet SSD criteria have greater disability than those who do not,[@b9-jpr-10-1411] indicating that FSS can be regarded as a mild disorder compared to SSD. Thus, we classified patients as having "FSS" if they complained of nonspecific pain, as well as if they had a diagnosis of FSS, such as irritable bowel disease, non-ulcer dyspepsia, premenstrual syndrome, chronic pelvic pain, fibromyalgia, atypical or noncardiac chest pain, chronic fatigue syndrome, tension headache, temporomandibular joint dysfunction, or atypical facial pain,[@b11-jpr-10-1411] when they did not meet the diagnostic criteria for SSD according to the DSM-5. Patients who met the criteria for both SSD and FSS were classified into the SSD group because most of such patients needed to be referred to psychiatrists, unlike cases of FSS only. However, the clinical position of FSS is unclear,[@b13-jpr-10-1411] in terms of whether it should be categorized within SSD or strictly distinguished as non-SSD. Moreover, this study aimed to develop a clinical score to discriminate SSD from MD, and physicians who diagnose patients with FSS-related disease based on their diagnostic criteria but omit the diagnosis of SSD would not strengthen the patients' somatic fixations because they are not concerned with MD; rather, they target functional improvement in such conditions. Therefore, we excluded FSS when developing our model, but investigated its nature in the validation phase.

Procedure
---------

We randomly matched two patients with MD (defined as "matched MD") by age (within two years), sex, and pain location (at least one part) for each definite SSD patient to exclude biases related to these factors and to generate a versatile model because the diagnoses and clinical features of MD differ according to these factors. The pain locations were divided into eight: whole body (if patients used the term or if parts included all the upper and lower limbs, and trunk), head and neck, chest, abdomen, back, upper limb, lower limb, and genital area. We decided upon eight clinical factors to investigate via focus-group discussions in our department, based on past reports and clinical experiences: analgesics ineffective (we defined analgesics as only acetaminophen or nonsteroidal anti-inflammatory drugs \[NSAIDs\]), unclear provocative/palliative factors, persistence without cessation, progression, mental disorder history, stress feelings/episodes (prior to the onset or aggravation of pain), complaints other than pain, and duration of six or more months (from the onset of pain to the first visit to our department). Two physicians independently checked each clinical record to extract the data. When the data were inconsistent, this was resolved by discussion with a third physician. Although all factors were evaluated by interview sheet or medical record history, unclear provocative/palliative factors were also evaluated by physical examination.

In the validation, probable SSD patients and MD patients who were unmatched to definite SSD patients (defined as "unmatched MD") were employed. All cases of SSD and all cases of MD were also employed because each SSD and MD group was not divided randomly, to prioritize confirming diagnoses of SSD in developing a model. To evaluate the nature of FSS, we assessed FSS + all SSD versus all MD, and all SSD versus FSS + all MD. Study approval was obtained from the institutional review board of the Graduate School of Medicine, Chiba University, without requirement of patient written consent because this study included no information that can reveal the identity of a particular individual, thus ensuring confidentiality of patient data.

Statistical analysis
--------------------

In the derivation, the factor of analgesics ineffective was evaluated according to 11 grades of improvement (0 \[no effect\] to 10 \[temporarily complete disappearance of pain\]). Missing data for this factor were substituted by the mean value of the two groups. We subsequently decided a binary cut-off value via the area under the receiver operating characteristic curve (AUC). Subsequently, the eight clinical factors of relevance to definite SSD and matched MD were evaluated by univariate analyses. The factors with a *P*-value of less than 0.15 in the univariate analyses were included in a conditional logistic regression model with forced entry method to identify the significant predictors (*p*\<0.05). The description utility of the model was evaluated by AUC, and the goodness of fit of the model was assessed using McFadden's pseudo-*R*-squared.

In the internal validation, the discrimination ability was assessed via AUC. The calibration was assessed by comparing the prevalence and the likelihood ratio of SSD according to the risk score. We regarded missing data for each factor as negative. We used StatsDirect version 3 (StatsDirect Ltd., Altricham, UK) for calculating the odds ratios for univariate analyses and SPSS Statistics for Windows version 22 (IBM Corp., Armonk, NY, USA) for other statistical analyses.

Results
=======

Characteristics of the participants
-----------------------------------

We show age, sex, and pain locations for each group in [Table 1](#t1-jpr-10-1411){ref-type="table"} and the final diagnoses of MD according to pain location in the Supplementary material. There were 104 cases of definite SSD and 197 cases of matched MD ([Figure 1](#f1-jpr-10-1411){ref-type="fig"}). Definite SSD cases that matched only one MD patient due to the lack of a matching case meeting all conditions consisted of the following, listed by pain location: four whole body (18-, 39-, 59-, and 68-year-old females), one head and neck (55-year-old female), one chest (65-year-old female), one back (38-year-old male), one upper limb (23-year-old female), and three genital area (60-year-old female and 61- and 66-year-old males). The number of cases of probable SSD, unmatched MD, and FSS was 214, 742, and 978, respectively ([Figure 1](#f1-jpr-10-1411){ref-type="fig"}).

Derivation
----------

Pain improvement according to 11 grades of analgesia was recorded in 59 (57%) cases of definite SSD and 82 (42%) cases of matched MD. Missing values were substituted with the mean value of 2.3, while effectiveness (including no record of concrete improvement grades), ineffectiveness, and missing data occurred in six (5.8%), 56 (54%), and 42 (40%) cases of definite SSD and 79 (40%), 32 (16%), and 86 (44%) cases of matched MD, respectively. The cut-off score was determined to be between 0 and 1 or more (AUC=0.789; 95% CI: 0.714--0.863, *p*\<0.001). All factors, except for progression, had a *p*-value of less than 0.15 in univariate analyses ([Table 2](#t2-jpr-10-1411){ref-type="table"}). In the conditional logistic regression analysis with forced entry method, the following five factors were included as independent predictors of SSD (*p*\<0.05) in decreasing order of odds ratios ([Table 3](#t3-jpr-10-1411){ref-type="table"}): mental disorder history, unclear provocative/palliative factors, analgesics ineffective, stress feelings/episodes, and persistence without cessation. The AUC of the model was 0.900 (95% CI: 0.864--0.937, *p*\<0.001; [Figure 2](#f2-jpr-10-1411){ref-type="fig"}), and the McFadden's pseudo-*R*-squared was 0.709.

Validation
----------

We show the results of five factors for probable SSD, unmatched MD, and FSS in [Table 4](#t4-jpr-10-1411){ref-type="table"}. AUC was 0.930 (95% CI: 0.910--0.950, *p*\<0.001) for probable SSD versus unmatched MD, 0.932 (95% CI: 0.916--0.949, *p*\<0.001) for all SSD versus all MD, 0.730 (95% CI: 0.710--0.751, *p*\<0.001) for all SSD + FSS versus all MD, and 0.881 (95% CI: 0.862--0.901, *p*\<0.001) for all SSD versus all MD + FSS ([Figure 2](#f2-jpr-10-1411){ref-type="fig"}). The prevalence and the likelihood ratio of SSD increased as the score increased ([Figures 3](#f3-jpr-10-1411){ref-type="fig"}[](#f4-jpr-10-1411){ref-type="fig"}[](#f5-jpr-10-1411){ref-type="fig"}--[6](#f6-jpr-10-1411){ref-type="fig"}). When we defined the cut-off score as between 1 and 2, corresponding to the largest sum of sensitivity and specificity, the score of the five factors had a sensitivity of 0.916 and a specificity of 0.849 for probable SSD versus unmatched MD, 0.906 and 0.852 for all SSD versus all MD, 0.543 and 0.852 for all SSD + FSS versus all MD, and 0.906 and 0.710 for all SSD versus all MD + FSS, respectively.

Discussion
==========

This is the first study to reveal the clinical features of SSD compared to MD, and to suggest a diagnostic score for non-acute pain. The following five factors composed the score: Analgesics ineffective, Mental disorder history, Unclear provocative/palliative factors, Persistence without cessation, and Stress feelings/episodes (A-MUPS). Based on the discrimination ability of the A-MUPS score according to AUC ([Figure 2](#f2-jpr-10-1411){ref-type="fig"}) and the stratified prevalence and likelihood ratio of SSD in the validation ([Figures 3](#f3-jpr-10-1411){ref-type="fig"}[](#f4-jpr-10-1411){ref-type="fig"}[](#f5-jpr-10-1411){ref-type="fig"}--[6](#f6-jpr-10-1411){ref-type="fig"}), the clinical features of FSS are more similar to those of MD than those of SSD. This indicates that the A-MUPS score reflects specific clinical features of SSD defined in the DSM-5, that it would be possible to assess whether patients with FSS had a diagnosis combined with SSD or not, and that the concept of SSD should be separated from that of FSS.

Factor "A" of the A-MUPS score was Analgesics ineffective. Acetaminophen and NSAIDs are recommended in the initial treatment for cancer and non-cancer pain.[@b15-jpr-10-1411] Besides pharmacological mechanisms, placebo analgesia, to which endogenous opioids and dopamine contribute, influences analgesic effects.[@b16-jpr-10-1411] Positive expectancies strengthen the degree of the placebo effect, while negative expectancies decrease the placebo effect, increase side effects, and induce nocebo effects.[@b17-jpr-10-1411] Although SSD patients visit multiple doctors as they seek care, the purpose of their behavior tends to be to persuade others that they are ill, so as to obtain illness-related privileges.[@b13-jpr-10-1411] These properties may contribute to the ineffectiveness of analgesics.

Factor "M" was Mental disorder history. The comorbidity of SSD with depression and/or anxiety is high, with a rate of 26%--59%,[@b18-jpr-10-1411] and patients with mental disorder tend to develop SSD.[@b19-jpr-10-1411] In a study of anxiety disorder, the proportion of cases with SSD that followed anxiety versus anxiety that followed SSD was the same, and simultaneous onset of these disorders was rare.[@b20-jpr-10-1411] Mental disorders influence each other.

Factor "U" was Unclear provocative/palliative factors. SSD patients complain of vague, imprecise, and changeable physical symptoms.[@b21-jpr-10-1411] Diagnostic criteria for SSD in the DSM-5 include "excessive thoughts, feelings, or behaviors related to somatic symptoms (criterion B)";[@b2-jpr-10-1411] functional, cortical issues would evoke or strengthen such symptoms. It is likely that no or minimal pain signal arises from the somatic organs, and thus, provocative/palliative factors cannot be clear.

Factor "P" was Persistence without cessation. Diagnostic criteria for SSD in the DSM-5 include persistence of symptoms.[@b2-jpr-10-1411] Although somatic symptoms need not be continuous,[@b22-jpr-10-1411] our study showed that the possibility of SSD increased if pain continued without cessation. Because SSD patients have a tendency of selective attention to physical symptoms,[@b18-jpr-10-1411] unceasing consciousness of their pain would be causative.

Factor "S" was stress feelings/episodes. Mental pain share a common neuroanatomical pathway with physical pain; the anterior cingulate cortex is related to the experience of pain distress, and the right ventral prefrontal cortex is related to the regulation of pain distress.[@b23-jpr-10-1411] Thus, cortical processing and interpretation of somatic signals depend on psychological salience,[@b24-jpr-10-1411] so that cognition, mood, and context influence pain perception.[@b25-jpr-10-1411] As SSD patients are more susceptible to pain than healthy individuals who are experiencing transient negative affect,[@b26-jpr-10-1411] the former are readily affected by stress.

SSD patients often complain of multiple symptoms,[@b14-jpr-10-1411] but pain tends to be the sole severe complaint.[@b2-jpr-10-1411] Although this is a reason why the factor "complaints other than pain" was not included in the model, some MD patients had objectively and easily identifiable complaints, including fever, swelling, and pallor. If we considered the quality of complaints, the factor may become of utility. Although the typical duration of symptoms is usually considered as more than six months, the factor "duration of six or more months" was also not included in the model. This suggests that SSD can be detected at an early stage, via other clinical features assessed by A-MUPS. Progression of pain generally indicates severe MD, while SSD patients attempt to convince others of their severe symptoms claiming aggravation.[@b27-jpr-10-1411] Thus, it is difficult to distinguish SSD from MD via the time course of pain.

Strengths and limitations of this study
=======================================

A strength of this study is its utilization of consecutive patients, most of whom were referred with unknown diagnostics. In addition, diagnoses were confirmed by two or more physicians who spent sufficient time to reach a satisfactory diagnosis, and diagnoses were also independently checked by another two physicians to minimize misdiagnosis. Moreover, we used the definite SSD data, which incorporated diagnosis by psychiatrists in our hospital with follow-up, to formulate our model. Although the results of the validation suggest the model is useful, these methods might have led to sampling bias.

Our study has several limitations. The possibility of sampling bias should be noted because the setting of this study was a single university hospital in Japan. Although our diagnoses of mental disorder including SSD were reconfirmed based on DSM-5 criteria by two or more independent physicians, they relied on medical records but not the medical practice itself. In addition, this was a retrospective cross-sectional study, although we tried to prevent recall bias and observer bias by double independent evaluations of medical records. Considering these limitations, we need to obtain prospective external validations in other multicenter settings. Mean-value substitution was used to replace missing data for the factor "analgesics ineffective" while generating the model because the proportion of missing data was high due to no prior prescription, absence of history, or the restricted definition of analgesics as those initially recommended (i.e., acetaminophen and NSAIDs).[@b15-jpr-10-1411] However, in the model formulation, the proportions of effectiveness (including no record of concrete improvement grades), ineffectiveness, and missing data were 5.8%, 54%, and 40% in definite SSD, and 40%, 16%, and 44% in matched MD, respectively, which shows a similar proportion of missing data but clearly greater ineffectiveness in definite SSD. Namely, substitution of missing data narrowed the difference between the two groups, but a significant difference was observed so that we consider this factor as a characteristic of SSD. Finally, because responses of SSD patients may change on a daily basis, such patients should receive repeated evaluations.

Conclusion
==========

This is the first study to develop a clinical diagnostic score (A-MUPS score) that differentiates patients with SSD from those with MD for complaints of non-acute pain. We expect the model will help to diagnose patients with SSD in consort with other validations. Further studies are needed to investigate the clinical features of SSD other than complaints of pain, the distinction between SSD and FSS, and the clinical differences among SSD, FSS, and other mental disorder.

Supplementary material
======================

###### 

Final diagnoses of medical diseases according to pain location

  Whole body                                                                                           
  -------------------------------------------------- ------------------------------------------------- -------------------------------------
  Polymyalgia rheumatica                             Spondyloarthritis                                 Myopathy
  Rheumatoid arthritis                                Psoriasis                                         Steroid
  Systemic lupus erythematosus                        Reactive arthritis                                Alcohol
  Behcet's disease                                    Undifferentiated                                 Viral infection
  Granulomatous polyarteritis                        Periodic paralysis                                 Parvo virus
  ACTH deficiency                                    Muscle cramp                                      Neuropathy
  Adrenal insufficiency                              Lymphoproliferative disease                        Diabetic
  Osteomalacia                                       Rhabdomyolysis                                    
                                                                                                       
  **Head and neck**                                                                                    
                                                                                                       
  Migraine                                           Malignancy                                        Trauma
  Cluster headache                                    Brain                                            Epilepsy
  Paroxysmal hemicrania                               Maxillary sinus                                  Giant cell arteritis
  Primary stabbing headache                           Hypopharyngeal                                   Relapsing polychondritis
  Trigeminal neuralgia                                Metastasis                                       PFAPA syndrome
  Primary headache associated with sexual activity   Dry eye                                           Kikuchi's disease
  Occipital neuralgia                                Glossitis                                         Crowned dens syndrome
  Mental neuralgia                                   Viral infection                                   Carotidynia
  Postherpetic neuralgia                              HIV                                              Subacute thyroiditis
  Zoster                                             Pheochromocytoma                                  Sinusitis
  Sleep apnea syndrome                               Spondyloarthritis                                 Scleritis
  Medication overuse headache                         Psoriasis                                        Dyskinesia
  Meningitis carcinomatosa                           Spondylosis                                       Parkinson's disease
  Benign tumor                                       Lichen planus                                     Syringomyelia
                                                                                                       
  **Chest**                                                                                            
                                                                                                       
  Angina pectoris                                    Eosinophilic gastritis                            Viral infection
  Aortic dissection                                  Intercostal neuralgia                              HIV
  Rupture of Valsalva sinus                          Postherpetic neuralgia                            Bornholm disease
  Takayasu arteritis                                 Costochondritis                                   Mondor's disease
  Systemic lupus erythematosus                       Gastric ulcer                                     Drug-induced myalgia
  SAPHO syndrome                                     Malignancy                                        Fracture
  Amyloidosis                                         Metastasis                                       Osteomalacia
  Familial Mediterranean fever                        Lymphoma                                         Muscle cramp
  Sarcoidosis                                         Multiple myeloma                                 Neuropathy
  Spondyloarthritis                                   Lung                                              Diabetic
   Reactive arthritis                                 Gastric                                          Subcutaneous abscess
   Ankylosing spondylitis                            Benign tumor                                      Pneumothorax
   Undifferentiated                                                                                    
                                                                                                       
  **Abdomen**                                                                                          
                                                                                                       
  Gastric ulcer                                      Idiopathic orchialgia                             Familial Mediterranean fever
  Appendicitis                                       Mesenteric panniculitis                           Amyloidosis
  Diverticulitis                                     Retroperitoneal fibrosis                          ACNES
  Invagination                                       Malignancy                                        Cholinergic urticaria
  Cholecystolithiasis                                 Gastric                                          Immunoglobulin A vasculitis
  Chronic pancreatitis                                Duodenum                                         Superior mesenteric artery syndrome
  Ovulation pain                                      Small intestine                                  Angina intestinalis
  Ileus                                               Colon                                            Discitis
  Eosinophilic gastroenteritis                        Biliary tract                                    Radiculopathy
  Crohn's disease                                     Pancreas                                         Intercostal neuralgia
  Constipation                                        Ovary                                            Chronic urticaria
  Renal abscess                                       Uterine body                                     Slipping rib syndrome
  Endometriosis                                       Kidney                                           Thrombophlebitis
  Hernia                                              Malignant lymphoma                               Pubic symphysis inflammation
   Inguinal hernia                                    Spinal cord                                      Zoster
   Abdominal incision                                 Metastasis                                       Trauma
  Salpingitis                                        Sarcoidosis                                       Neuropathy
  Pelvic inflammatory disease                        Systemic lupus erythematosus                       Diabetic
                                                                                                       
  **Back**                                                                                             
                                                                                                       
  Spondylosis                                        Spinal canal stenosis                             Chronic pancreatitis
  Radiculopathy                                      Pneumothorax                                      Malignancy
  Fracture                                           Drug-induced myalgia                               Metastasis
  Intercostal neuralgia                              Tight filum terminale                              Pancreas
  Discitis                                           Osteomalacia                                       Multiple myeloma
  Costochondritis                                    SAPHO syndrome                                     Malignant lymphoma
  Postherpetic neuralgia                             Spondyloarthritis                                  Lung
  Bornholm disease                                    Reactive arthritis                                Pleural mesothelioma
  Viral infection                                     Ankylosing spondylitis                            Gastric
   Cytomegalovirus                                   Amyloidosis                                        Unknown primary
  Myositis                                           Systemic lupus erythematosus                      Neuropathy
   Streptococcus                                     Polymyalgia rheumatica                             Diabetic
  Myopathy                                           Familial Mediterranean fever                      Parkinson's disease
   Steroid                                           Cholinergic urticaria                             Gastric ulcer
  Ossification of the ligamentum flavum                                                                
                                                                                                       
  **Upper limb**                                                                                       
                                                                                                       
  Rheumatoid arthritis                               Frozen shoulder                                   Plexopathy
  Palindromic rheumatism                             Gout                                               Diabetic
  Polymyalgia rheumatica                             Pseudogout                                        Lateral epicondylitis
  RS3PE                                              Trigger finger                                    CIDP
  Mixed connective tissue disease                    Painful arc                                       Complex regional pain syndrome
  Antiphospholipid syndrome                          Cubital tunnel syndrome                           Angioedema with eosinophilia
  Behcet's disease                                   Radiculopathy                                     Lymphoadenitis
  Dermatomyositis                                    Syringomyelia                                      Tuberculosis
  Systemic lupus erythematosus                       Ossification of posterior longitudinal ligament   Kikuchi's disease
  Sjogren's syndrome                                 Myelopathy                                        Parkinson's disease
  Scleroderma                                        Glomangioma                                       ACTH deficiency
  Graves' disease                                    Wartenberg's syndrome                             Hypopituitarism
  Familial Mediterranean fever                       Frostbite                                         Adrenal insufficiency
  Spondyloarthritis                                  Drug-induced myalgia                              Malignancy
   Psoriasis                                         Rotator cuff tear                                  Lung (Pancoast tumor)
   Inflammatory bowel disease                        Myopathy                                           Malignant lymphoma
   Reactive arthritis                                 Hypokalemia                                       Multiple myeloma
   Undifferentiated                                  Viral infection                                   Myelodysplastic syndrome
  Osteoarthritis                                      Parvo virus                                      Angina pectoris
  Carpal tunnel syndrome                              Cytomegalovirus                                  Raynaud syndrome
  Calcific tendinitis                                Neuropathy                                        Thoracic outlet syndrome
  Tenosynovitis                                       Diabetic                                         Neuralgia
                                                                                                       
  **Lower limb**                                                                                       
                                                                                                       
  Radiculopathy                                      Baker's cyst                                      Postherpetic neuralgia
  Pubic symphysis inflammation                       Femur head necrosis                               Neuropathy
  Spinal canal stenosis                              Stasis dermatitis                                  Alcoholic
  Metatarsalgia                                      Livedo reticularis                                 Diabetic
  Epiphysiopathy                                     Angioedema with eosinophilia                       Vitamin B1 deficiency
  Tenosynovitis                                      Eosinophilic fasciitis                            CIDP
  Piriformis syndrome                                Spondyloarthritis                                 Restless legs syndrome
  Osteochondritis dissecans                           Reactive arthritis                               Complex regional pain syndrome
  Varicosis                                           Psoriasis                                        Erythromegalgia
  Bursitis                                            Ankylosing spondylitis                           ACTH deficiency
  Myositis                                            Undifferentiated                                 Hypopituitarism
   Streptococcus                                     Rheumatoid arthritis                              Adrenal insufficiency
  Myopathy                                           Palindromic rheumatism                            Painless thyroiditis
   Hypothyroid                                       Mixed connective tissue disease                   Osteomalacia
  Tarsal tunnel syndrome                             Familial Mediterranean fever                      Peripheral artery disease
  Ossification of posterior longitudinal ligament    Dermatomyositis                                   Raynaud syndrome
  Erythema nodosum                                   Polymyositis                                      Malignancy
  Morton's disease                                   Focal myositis                                     Chondrosarcoma
  Meniscus injury                                    Behcet's disease                                   Uterine cervix
  Panniculitis                                       Systemic lupus erythematosus                       Multiple myeloma
  Viral infection                                    Immunoglobulin A vasculitis                        Malignant lymphoma
   Parvo virus                                       Cryoglobulinemia vasculitis                        Metastasis
   Cytomegalovirus                                   Polyarteritis nodosa                              Benign tumor
  Plantar fasciitis                                  Polymyalgia rheumatica                            Myelodysplastic syndrome
  Gout                                               RS3PE                                             Hernia
  Pseudogout                                         Sjogren's syndrome                                 Obturator
  Neuralgia                                          Graves' disease                                    Inguinal
   Obturator                                         Muscle cramp                                      Lymphadenitis
   Lateral femoral cutaneous nerve                   Parkinson's disease                               Frostbite
                                                                                                       
  **Genital area**                                                                                     
                                                                                                       
  Malignancy                                         Hemorrhoid                                        Pudendal neuralgia
   Bladder, ureter                                   Familial Mediterranean fever                      Adhesive arachnoiditis
  Cholinergic urticaria                              Retroperitoneal fibrosis                          

**Abbreviations:** ACTH, adrenocorticotropic hormone; PFAPA, periodic fever, aphthous stomatitis, pharyngitis, and adenitis; SAPHO, synovitis, acne, pustulosis, hyperostosis, and osteitis; ACNES, abdominal cutaneous nerve entrapment syndrome; RS3PE, remitting seronegative symmetrical synovitis with pitting edema; CIDP, chronic inflammatory demyelinating polyneuropathy.

The authors would like to thank Editage for the English language editing.

**Disclosure**

The authors report no conflicts of interest in this work.

![Flowchart and classification of the patients.\
**Notes:** \*Including SSD if the primary diagnosis was another mental disorder. ^§^Not combined with the diagnosis of SSD.\
**Abbreviations:** SSD, somatic symptom disorder; FSS, functional somatic syndrome; MD, medical disease.](jpr-10-1411Fig1){#f1-jpr-10-1411}

![Receiver operating characteristic curves according to the five scores in derivation and validation phases.\
**Abbreviations:** SSD, somatic symptom disorder; MD, medical disease; FSS, functional somatic syndrome.](jpr-10-1411Fig2){#f2-jpr-10-1411}

![Prevalence and likelihood ratio of SSD in validation phase (probable SSD versus unmatched MD).\
**Abbreviations:** A-MUPS, Analgesics ineffective, Mental disorder history, Unclear provocative/palliative factors, Persistence without cessation, and Stress feelings/episodes; SSD, somatic symptom disorder; MD, medical disease; NA, not applicable.](jpr-10-1411Fig3){#f3-jpr-10-1411}

![Prevalence and likelihood ratio of SSD in validation phase (all SSD versus all MD).\
**Abbreviations:** A-MUPS, Analgesics ineffective, Mental disorder history, Unclear provocative/palliative factors, Persistence without cessation, and Stress feelings/episodes; SSD, somatic symptom disorder; MD, medical disease; NA, not applicable.](jpr-10-1411Fig4){#f4-jpr-10-1411}

![Prevalence and likelihood ratio of SSD + FSS in validation phase (all SSD + FSS versus all MD).\
**Abbreviations:** A-MUPS, Analgesics ineffective, Mental disorder history, Unclear provocative/palliative factors, Persistence without cessation, and Stress feelings/episodes; SSD, somatic symptom disorder; FSS, functional somatic syndrome; MD, medical disease; NA, not applicable.](jpr-10-1411Fig5){#f5-jpr-10-1411}

![Prevalence and likelihood ratio of SSD in validation phase (all SSD versus all MD + FSS).\
**Abbreviations:** A-MUPS, Analgesics ineffective, Mental disorder history, Unclear provocative/palliative factors, Persistence without cessation, and Stress feelings/episodes; SSD, somatic symptom disorder; MD, medical disease; FSS, functional somatic syndrome.](jpr-10-1411Fig6){#f6-jpr-10-1411}

###### 

Age, gender, and pain location in each group

  Basic information                                       Derivation    Validation                                                      
  ------------------------------------------------------- ------------- ------------- ------- ------------- ------------- ------------- ---------
  Age                                                     52.0 (16.6)   52.1 (16.4)   0.97    47.3 (16.5)   54.2 (18.0)   48.7 (18.1)   \<0.001
  Male                                                    42 (40%)      79 (40%)      0.96    69 (32%)      345 (46%)     437 (45%)     0.009
  Location[\*](#tfn1a-jpr-10-1411){ref-type="table-fn"}                                                                                 
   Whole body                                             16 (15%)      28 (14%)      0.78    57 (27%)      41 (6%)       39 (4%)       \<0.001
   Head, neck                                             35 (34%)      46 (23%)      0.055   53 (25%)      120 (16%)     297 (30%)     \<0.001
   Chest                                                  20 (19%)      30 (15%)      0.38    15 (7%)       106 (14%)     154 (16%)     0.004
   Abdomen                                                29 (28%)      51 (26%)      0.71    46 (21%)      131 (18%)     319 (33%)     \<0.001
   Back                                                   21 (20%)      38 (19%)      0.85    42 (20%)      97 (13%)      184 (19%)     0.003
   Upper limb                                             14 (13%)      22 (11%)      0.56    22 (10%)      155 (21%)     61 (6%)       \<0.001
   Lower limb                                             11 (11%)      30 (15%)      0.26    36 (17%)      229 (31%)     70 (7%)       \<0.001
   Genital area                                           4 (4%)        4 (2%)        0.45    6 (3%)        6 (1%)        24 (2%)       0.025

**Notes:** Data are mean (SD) or n (%).

Multiple locations could be chosen, except in the case of whole body, if patients suffered pain in multiple regions.

**Abbreviations:** SSD, somatic symptom disorder; MD, medical disease; FSS, functional somatic syndrome.

###### 

Univariate analysis of the eight factors between definite SSD and matched MD

  Factors                                                  Definite SSD, n=104   Matched MD, n=197   Odds ratio   95% CI       *p*-value
  -------------------------------------------------------- --------------------- ------------------- ------------ ------------ -----------
  Analgesics[\*](#tfn3-jpr-10-1411){ref-type="table-fn"}                                                                       
   Effective                                               48 (46%)              165 (84%)           Ref                       
   Ineffective                                             56 (54%)              32 (16%)            6.02         3.39--10.7   \<0.001
   Missing data                                            0 (0%)                0 (0%)              NA           NA           NA
  Provocative/palliative factors                                                                                               
   Clear                                                   33 (32%)              153 (78%)           Ref                       
   Unclear                                                 71 (68%)              43 (22%)            7.66         4.34--13.5   \<0.001
   Missing data                                            0 (0%)                1 (\<1%)            NA           NA           NA
  Persistence                                                                                                                  
   With cessation                                          30 (29%)              131 (66%)           Ref                       
   Without cessation                                       73 (70%)              63 (32%)            5.06         2.02--8.84   \<0.001
   Missing data                                            1 (1%)                3 (2%)              1.46         0.03--18.8   0.57
  Progression                                                                                                                  
   Progressing                                             36 (35%)              55 (28%)            Ref                       
   Nonprogressing                                          64 (62%)              140 (71%)           0.70         0.41--1.21   0.18
   Missing data                                            4 (4%)                2 (1%)              3.06         0.41--35.0   0.23
  Mental disorder history                                                                                                      
   Existent                                                20 (19%)              9 (5%)              4.91         2.02--12.7   \<0.001
   Nonexistent                                             81 (78%)              179 (91%)           Ref                       
   Missing data                                            3 (3%)                9 (5%)              0.74         0.13--3.06   0.76
  Stress feelings/episodes                                                                                                     
   Existent                                                55 (53%)              33 (17%)            5.67         3.13--10.3   \<0.001
   Nonexistent                                             40 (38%)              136 (69%)           Ref                       
   Missing data                                            9 (9%)                28 (14%)            1.09         0.42--2.63   0.83
  Complaints other than pain                                                                                                   
   Existent                                                58 (56%)              64 (32%)            2.62         1.56--4.40   \<0.001
   Nonexistent                                             46 (44%)              133 (68%)           Ref                       
   Missing data                                            0 (0%)                0 (0%)              NA           NA           NA
  Duration                                                                                                                     
   Six or more months                                      71 (68%)              107 (54%)           1.87         1.10--3.20   0.019
   Under six months                                        32 (31%)              90 (46%)            Ref                       
   Missing data                                            1 (1%)                0 (0%)              NA           NA           NA

**Note:**

Missing data were substituted by the mean value of the two groups.

**Abbreviations:** SSD, somatic symptom disorder; MD, medical disease; Ref, reference; NA, not applicable.

###### 

Conditional logistic regression analysis of the factors with *p*\<0.15 in univariate analysis

  Factors                                 Regression *β* coefficient   Odds ratio   95% CI       *p*-value
  --------------------------------------- ---------------------------- ------------ ------------ -----------
  Mental disorder history                 2.64                         14.1         3.49--56.6   \<0.001
  Unclear provocative/palliative factor   2.32                         10.2         3.71--28.1   \<0.001
  Analgesics ineffective                  2.28                         9.73         3.44--27.4   \<0.001
  Stress feelings/episodes                2.12                         8.29         2.69--25.5   \<0.001
  Persistence without cessation           1.90                         6.69         2.25--19.9   0.001
  Complaints other than pain              0.85                         2.35         0.91--6.06   0.078
  Duration of six or more months          0.65                         1.92         0.83--4.44   0.13

###### 

The five factors for probable SSD, unmatched MD, and FSS in the validation phase

  Factors                          Probable SSD, n=214   Unmatched MD, n=742   FSS, n=978
  -------------------------------- --------------------- --------------------- ------------
  Analgesics                                                                   
   Effective                       25 (12%)              264 (36%)             188 (19%)
   Ineffective                     106 (50%)             99 (13%)              151 (15%)
   Missing data                    83 (39%)              379 (51%)             639 (65%)
  Provocative/palliative factors                                               
   Clear                           41 (19%)              593 (80%)             520 (53%)
   Unclear                         171 (80%)             145 (20%)             445 (46%)
   Missing data                    2 (\<1%)              4 (\<1%)              13 (1%)
  Persistence                                                                  
   With cessation                  56 (26%)              493 (66%)             699 (71%)
   Without cessation               157 (73%)             240 (32%)             264 (27%)
   Missing data                    1 (\<1%)              9 (1%)                15 (2%)
  Mental disorder history                                                      
   Existent                        68 (32%)              45 (6%)               111 (11%)
   Nonexistent                     141 (66%)             671 (90%)             812 (83%)
   Missing data                    5 (2%)                26 (4%)               54 (6%)
  Stress feelings/episodes                                                     
   Existent                        113 (53%)             58 (8%)               364 (37%)
   Nonexistent                     93 (43%)              544 (73%)             490 (50%)
   Missing data                    8 (4%)                130 (18%)             124 (13%)

**Abbreviations:** SSD, somatic symptom disorder; MD, medical disease; FSS, functional somatic syndrome.
